First Trust NYSE Arca Biotechnology Index Fund (NYSEARCA:FBT – Get Free Report) traded up 0.6% during trading on Monday . The company traded as high as $270.82 and last traded at $269.73. Approximately 26,492 shares traded hands during trading, a decline of 76% from the average session volume of 110,409 shares. The stock had previously closed at $268.15.
First Trust NYSE Arca Biotechnology Index Fund Trading Up 0.6%
The company has a fifty day moving average price of $259.46 and a two-hundred day moving average price of $230.66. The firm has a market cap of $2.98 billion, a P/E ratio of 21.72 and a beta of 0.67.
Institutional Trading of First Trust NYSE Arca Biotechnology Index Fund
Institutional investors have recently modified their holdings of the company. First Trust Advisors LP raised its position in First Trust NYSE Arca Biotechnology Index Fund by 49,660.7% in the 1st quarter. First Trust Advisors LP now owns 3,515,093 shares of the company’s stock valued at $705,900,000 after buying an additional 3,508,029 shares during the last quarter. Royal Bank of Canada lifted its stake in First Trust NYSE Arca Biotechnology Index Fund by 29.1% in the 1st quarter. Royal Bank of Canada now owns 199,981 shares of the company’s stock valued at $40,160,000 after acquiring an additional 45,112 shares in the last quarter. World Investment Advisors boosted its position in First Trust NYSE Arca Biotechnology Index Fund by 275.6% during the 1st quarter. World Investment Advisors now owns 29,734 shares of the company’s stock worth $5,971,000 after acquiring an additional 21,817 shares during the last quarter. Gateway Wealth Partners LLC boosted its position in First Trust NYSE Arca Biotechnology Index Fund by 174.5% during the 1st quarter. Gateway Wealth Partners LLC now owns 19,654 shares of the company’s stock worth $3,947,000 after acquiring an additional 12,495 shares during the last quarter. Finally, Bank of America Corp DE boosted its position in First Trust NYSE Arca Biotechnology Index Fund by 5.7% during the 1st quarter. Bank of America Corp DE now owns 200,959 shares of the company’s stock worth $40,357,000 after acquiring an additional 10,853 shares during the last quarter.
About First Trust NYSE Arca Biotechnology Index Fund
The First Trust NYSE Arca Biotechnology Index Fund (FBT) is an exchange-traded fund that is based on the NYSE Arca Biotechnology index. The fund tracks an equal-weighted index of US biotechnology stocks. FBT was launched on Jun 19, 2006 and is managed by First Trust.
Featured Stories
- Five stocks we like better than First Trust NYSE Arca Biotechnology Index Fund
- Can Bloom Energy Pop the Top Off AI’s Massive Energy Bottleneck?
- Coach’s Momentum Powers Tapestry Despite the Stock’s Sharp Pullback
- AI Is Reshaping SaaS—These 2 Software ETFs Offer Different Ways to Play It
- Insiders Signal Deep Value In DICK’s Sporting Goods
Receive News & Ratings for First Trust NYSE Arca Biotechnology Index Fund Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for First Trust NYSE Arca Biotechnology Index Fund and related companies with MarketBeat.com's FREE daily email newsletter.
